Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 9;20(5):716-718.
doi: 10.1093/neuonc/noy014.

IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas

Romain Appay  1   2 , Emeline Tabouret  3   2 , Nicolas Macagno  1   2 , Mehdi Touat  4   5 , Catherine Carpentier  2   5 , Carole Colin  2   5 , François Ducray  6   7 , Ahmed Idbaih  4   5 , Karima Mokhtari  5   8 , Emmanuelle Uro-Coste  9   10 , Caroline Dehais  4 , Dominique Figarella-Branger  1   2 ; POLA Network
Collaborators, Affiliations

IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas

Romain Appay et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Integrated diagnosis of the 1025 IDH-mutant cases of the French POLA cohort according to the updated fourth WHO classification and representative fluid attenuated inversion recovery MRI axial sections among the subgroups of anaplastic oligodendroglioma, IDH-mutant, and 1p/19q codeleted.
See this image and copyright information in PMC

References

    1. Louis DN, Perry A, Reifenberger G et al. . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
    1. Yan H, Parsons DW, Jin G et al. . IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360(8):765–773. - PMC - PubMed
    1. Tabouret E, Nguyen AT, Dehais C et al. ; For POLA Network Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort. Acta Neuropathol. 2016;132(4):625–634. - PubMed
    1. Wang HY, Tang K, Liang TY et al. . The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas. J Exp Clin Cancer Res. 2016;35:86. - PMC - PubMed
    1. Watanabe T, Nobusawa S, Kleihues P, Ohgaki H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol. 2009;174(4):1149–1153. - PMC - PubMed

Publication types